Literature DB >> 12416541

Adenovirus-mediated gene transfer of B7.1 induces immunological anti-tumor effects in a murine brain tumor.

Jun Morioka1, Koji Kajiwara, Koichi Yoshikawa, Makoto Ideguchi, Tetsuya Uchida, Yoshinori Ohmoto, Michiyasu Suzuki.   

Abstract

The purpose of the present study was to determine if adenovirus-mediated transfection of a syngeneic mouse brain tumor with the gene encoding B7.1 enhances immunogenicity against tumor. Malignant astrocytoma cells were transfected with adenoviral vectors carrying the B7.1 gene (AdB7). Immunocytochemical analysis confirmed the expression of B7.1 in vitro and in vivo. To investigate the effects of B7.1 expression on tumorigenicity of the malignant astrocytoma, mice were implanted intracerebrally with B7.1-transfected glioma cells. There was no significant difference in proliferation between B7.1-transfected cells and controls in vitro. Nevertheless, mice implanted with B7. 1-transfected cells survived significantly longer than those in the control groups. Immunocytochemical analysis of the tumors showed that there was infiltration of a number of CD8+ T-cells and CD25+ activated T-cells in the brain implanted with B7.1-transfected glioma cells. The results showed the possibility that adenovirus-mediated B7.1 gene transfection to a brain tumor induced activation of CD8+ cytotoxic T-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12416541     DOI: 10.1023/a:1020260822669

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  33 in total

Review 1.  Toward a genetic analysis of tumor rejection antigens.

Authors:  T Boon
Journal:  Adv Cancer Res       Date:  1992       Impact factor: 6.242

2.  Gene therapy with modified tumor cells enables T-cell activation by stimulating pathways required for signal transduction.

Authors:  S Salvadori; K Zier
Journal:  Cytokines Mol Ther       Date:  1996-09

3.  B7-1(CD80)-transfected human glioma cells and interleukin-12 directly stimulate allogeneic CD8+ T cells.

Authors:  T Komata; R Tanaka; K Yamamoto; T Oda; K Ono; S Yoshida; M Takahashi
Journal:  J Immunother       Date:  1997-07       Impact factor: 4.456

4.  Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.

Authors:  J P Zou; L A Morford; C Chougnet; A R Dix; A G Brooks; N Torres; J D Shuman; J E Coligan; W H Brooks; T L Roszman; G M Shearer
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

5.  Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors.

Authors:  L A Morford; A R Dix; W H Brooks; T L Roszman
Journal:  J Neurosurg       Date:  1999-12       Impact factor: 5.115

6.  Transfer of a foreign gene into the brain using adenovirus vectors.

Authors:  S Akli; C Caillaud; E Vigne; L D Stratford-Perricaudet; L Poenaru; M Perricaudet; A Kahn; M R Peschanski
Journal:  Nat Genet       Date:  1993-03       Impact factor: 38.330

7.  Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death.

Authors:  L G Radvanyi; G B Mills; R G Miller
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

8.  Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.

Authors:  P Yeh; J F Dedieu; C Orsini; E Vigne; P Denefle; M Perricaudet
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.

Authors:  L Chen; P McGowan; S Ashe; J Johnston; Y Li; I Hellström; K E Hellström
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

10.  CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

Authors:  M F Krummel; J P Allison
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.

Authors:  James F Curtin; Gwendalyn D King; Marianela Candolfi; Remy B Greeno; Kurt M Kroeger; Pedro R Lowenstein; Maria G Castro
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

Review 2.  Adenoviral vector-mediated gene therapy for gliomas: coming of age.

Authors:  Maria G Castro; Marianela Candolfi; Thomas J Wilson; Alexandra Calinescu; Christopher Paran; Neha Kamran; Carl Koschmann; Mariela A Moreno-Ayala; Hikmat Assi; Pedro R Lowenstein
Journal:  Expert Opin Biol Ther       Date:  2014-04-29       Impact factor: 4.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.